Clinical Compound Library

(1957 compounds) Cat. No.: HY-L026: Library Contents: XLSX PDF

New drug development is a time-consuming and high-cost process. Drug repurposing (also called drug repositioning, reprofiling or re‑tasking) offers various advantages over developing an entirely new drug for a given indication, such as lower risk and less investment. Clinical drugs have confirmed bioactivities, clear mechanisms and high safety that are suitable for drug repurposing.

MCE owns a unique collection of 1957 clinical compounds that refer to various research areas including anti-cancer, anti-infection, anti-inflammation, nervous disease. Those compounds are of detailed information on clinical development status, research area, targets, etc.

Size (Pre-dissolved DMSO or Solid)	Price	Stock
30 μL/well (10 mM solution)	Get quote	In-stock
50 μL/well (10 mM solution)	Get quote	In-stock
100 μL/well (10 mM solution)	Get quote	In-stock
250 μL/well (10 mM solution)	Get quote	In-stock

Download Screening Library Catalog

Please contact us at

sales@MedChemExpress.com

Clinical Compound Library

Customer Validation